Equities

Goodrx Holdings Inc

GDRX-RM:MCX

Goodrx Holdings Inc

Actions
  • Price (--)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
--
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

GoodRx Holdings, Inc. is a consumer-focused digital healthcare platform. The Company provides GoodRx platform, which aggregates and analyzes pricing data from a range of different sources. The platform provides access to medication savings programs, medical provider consultations and lab tests through its telehealth offerings, GoodRx Care and the GoodRx Telehealth Marketplace, and other healthcare related content. Its prescription offering provides price comparisons and negotiated prices on prescriptions. Its subscription offerings provide consumers and their families with access to lower prescription prices on select medications in select pharmacies for a monthly or annual subscription fee. Its pharma manufacturers provide affordability solutions such as co-pay cards, patient assistance programs, care portals and other savings options. Its prescription transactions offering provides curated, geographically relevant price comparisons and negotiated prices on prescriptions

  • Revenue in USD (TTM)795.70m
  • Net income in USD-70.77m
  • Incorporated2015
  • Employees756.00
  • Location
    Goodrx Holdings Inc2701 Olympic Boulevard, Suite 990SANTA MONICA 90404United StatesUSA
  • Fax+1 (302) 636-5454
  • Websitehttps://investors.goodrx.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
GDRX:NSQ since
announced
Transaction
value
VitaCare Prescription Services IncDeal completed07 Mar 202207 Mar 2022Deal completed-72.72%157.00m
Data delayed at least 15 minutes, as of Nov 30 2022 21:00 GMT.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.